Key result
Management of PIVSD yielded 58.3% overall 30-day mortality.
Why the study?
Post-infarction ventricular septal defect is a rare, life-threatening complication of acute myocardial infarction, and patient-level data across surgical repair, transcatheter closure, and conservative management remain limited.
What are the clinical characteristics and 30-day all-cause mortality outcomes across surgical repair, transcatheter closure, and conservative management in adult patients with post-infarction ventricular septal defect?
Cohort (n=24)
No
What are the clinical characteristics and 30-day all-cause mortality outcomes across surgical repair, transcatheter closure, and conservative management in adult patients with post-infarction ventricular septal defect?
Post-infarction ventricular septal defect carries a high 30-day mortality (58.3% overall), with surgical repair demonstrating the lowest early mortality (35.7%) compared to transcatheter closure (100%) and conservative management (83.3%) in this single-center cohort.
Answers are grounded in this paper and cite their sources.
High early mortality across strategies warrants caution; leaves open optimal management selection in post-infarction ventricular septal defect.
Background/Objectives: Post-infarction ventricular septal defect (PIVSD) is a rare but life-threatening mechanical complication of acute myocardial infarction (AMI). Surgical repair remains the standard treatment, while transcatheter closure represents an alternative in selected patients. However, patient-level data across all management strategies, including conservative management, remain limited. This study aims to describe the clinical characteristics, management strategies, and early outcomes of patients with PIVSD. Methods: We conducted a retrospective, single-center study of consecutive adult patients with PIVSD managed by surgical repair, transcatheter closure, or conservative management between 2009 and 2025. The primary outcome was 30-day all-cause mortality. All analyses were descriptive. Results: Twenty-four patients were included (surgical repair n = 14, transcatheter closure n = 4, conservative management n = 6). Median age was 79.0 years (IQR 72.0–83.0), and 12 (50%) were female. The median time from AMI symptom onset to PIVSD diagnosis was 31 h (IQR 21–104). Cardiogenic shock was present at presentation in 16 patients (66.7%), and pre-intervention mechanical circulatory support (MCS) was used in 14 (58.3%). Thirty-day mortality was 58.3% overall (surgical repair 35.7%, transcatheter closure 100%, conservative management 83.3%). The four transcatheter patients were elderly (median age 83.5 years), and all required pre-intervention MCS. Residual shunting persisted in all of them, and one post-mortem examination six days after closure showed fibrin-rich thrombus on the occluder without mature endothelialization. Conclusions: PIVSD remains associated with high early mortality. Management depends on hemodynamic status, patient characteristics, anatomical considerations, and treatment goals. Multidisciplinary Heart Team evaluation remains essential to guide individualized management.
No takes yet. Share an insight, caveat, or question.
Chal et al. (2026) conducted a cohort in Post-infarction ventricular septal defect (PIVSD) complicating acute myocardial infarction (n=24). Surgical repair, transcatheter closure, or conservative management was evaluated on 30-day all-cause mortality. Management of PIVSD yielded 58.3% overall 30-day mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: